Kiera Hardy

• MBBS
• Retrospective study into T1 (early stage) rectal cancer treatments and associated oncological outcomes.

Rectal cancer has an incidence of 14,000 cases per year in the UK, with early stage disease accounting for 17% of patients. Traditionally, treatment has been extensive surgical removal of the tumour. However, newer endoscopic treatments may be better for patient outcomes.   

The research project involved looking through the notes of approximately 500 patients in the North East who underwent either surgical or endoscopic treatment for T1 rectal cancers. The aim of the project was to establish variations in treatments, and the associated outcomes of each treatment. Specifically, the reoccurrence of cancer with endoscopic treatments, which involves removal of only the isolated cancer lesion, and more extensive surgical treatments such as removal of the rectum. The results of the research will be used to establish a best practice guideline for future patient management in colorectal surgery. 

Funding source: Newcastle University

Supervisor: Mr Fadlo Shaban & Mr Peter Coyne